. 2016 Mar 22;11:611–622. doi: 10.2147/COPD.S88846

Table 3.

POPE study – captured parameters

Form	Parameter
History	Demographic data
	Age of first diagnosis
	History of allergy/atopy
	COPD symptoms
	Smoking history
	Other than tobacco smoking risk factors^a
	History of acute respiratory events
	Concomitant respiratory diseases
	Weight assessment
	Comorbidities – Charlson comorbidity index
	Comorbidities – others
Physical examination	BMI
	Heart and breath frequency
	Physical signs of COPD and heart failure sings
Pulmonary function	Postbronchodilator spirometry values
	Body plethysmography (TLC and RV)^b
	TL_CO and K_CO^b
	Bronchodilator test^b
	Bronchial challenge test^b
	FeNO^b
	HRCT of thorax^b
	Echocardiography^b
	Blood/sputum eosinophil assessment^b
	6-minute walk test^b
	Total serum IgE measurement^b
	ABG^b
	HCT^b
Questionnaires	CAT (total score and all 8 items separately)
	mMRC
Treatment	COPD pharmacological and nonpharmacological treatment
	Other respiratory treatment
	LTOT
	Surgery and BVR
	Vaccination
	Nonrespiratory concomitant treatment

Notes:

Required in nonsmokers,

optional.

Abbreviations: ABG, arterial blood gas; BMI, body mass index; BVR, bronchoscopic lung volume reduction; CAT, the COPD assessment test; COPD, chronic obstructive pulmonary disease; FeNO, fractional exhaled nitric oxide; HCT, hematocrit; HRCT, high-resolution computed tomography; IgE, immunoglobulin E; K_CO, Krogh factor; LTOT, long-term oxygen therapy; mMRC, modified Medical Research Council dyspnea scale; RV, residual volume; TLC, total lung capacity; TL_CO, transfer factor.